These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7768075)

  • 21. Pharmacokinetics of halofantrine in Thai patients with acute uncomplicated falciparum malaria.
    Karbwang J; Milton KA; Na Bangchang K; Ward SA; Edwards G; Bunnag D
    Br J Clin Pharmacol; 1991 Apr; 31(4):484-7. PubMed ID: 2049260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and tolerance of extended-dose halofantrine for drug-resistant falciparum malaria in Thailand.
    Watt G; Loesuttiviboon L; Jongsakul K; Shanks GD; Ohrt CK; Karnasuta C; Schuster B; Fleckenstein L
    Am J Trop Med Hyg; 1994 Feb; 50(2):187-92. PubMed ID: 8116811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of retinyl palmitate and retinol after intramuscular retinyl palmitate administration in severe malaria.
    Davis TM; Binh TQ; Thu LT; Rossi R; Danh PT; Barrett PH; Beilby J
    Clin Sci (Lond); 2000 Nov; 99(5):433-41. PubMed ID: 11052924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of mefloquine when given as a single and two divided-dose regimens.
    Na-Bangchang K; Molunto P; Banmairuroi V; Thanavibul A; Karbwang J
    Int J Clin Pharmacol Res; 1995; 15(5-6):215-20. PubMed ID: 8835620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short report: in vivo sensitivity of Plasmodium falciparum to halofantrine in southern central Vietnam.
    Doan HN; Taylor WR; Nguyen DT; Tran TU; Fryauff DJ; Susanti I; Gómez-Saladín E; Le DC; Baird JK
    Am J Trop Med Hyg; 2003 Nov; 69(5):553-4. PubMed ID: 14695095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The halofantrine treatment of Plasmodium falciparum malaria. Clinical experience].
    Villota Arrieta J; Barreiro Casal G; García López M; Cilleruelo Ortega MJ; Mellado Peña MJ; Pérez Jurado ML; Martín Fontelos P
    An Esp Pediatr; 1996 Feb; 44(2):117-20. PubMed ID: 8830568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of micronized halofantrine in semi-immune patients with acute uncomplicated falciparum malaria in Cameroon.
    Fadat G; Louis FJ; Louis JP; Le Bras J
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1955-7. PubMed ID: 8239611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postexposure administration of halofantrine for the prevention of malaria.
    Shanks GD; Edstein MD; Kereu RK; Spicer PE; Rieckmann KH
    Clin Infect Dis; 1993 Oct; 17(4):628-31. PubMed ID: 8268342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of halofantrine in healthy Thai volunteers.
    Karbwang J; Ward SA; Milton KA; Na Bangchang K; Edwards G
    Br J Clin Pharmacol; 1991 Nov; 32(5):639-40. PubMed ID: 1954081
    [No Abstract]   [Full Text] [Related]  

  • 30. Halofantrine in the treatment of malaria.
    Lancet; 1989 Sep; 2(8662):537-8. PubMed ID: 2570238
    [No Abstract]   [Full Text] [Related]  

  • 31. [A new antimalarial on the market: halofantrine. Various observations].
    Picq JJ
    Med Trop (Mars); 1989; 49(1):87-9. PubMed ID: 2657315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics, efficacy and toxicity of parenteral halofantrine in uncomplicated malaria.
    Krishna S; ter Kuile F; Supanaranond W; Pukrittayakamee S; Teja-Isavadharm P; Kyle D; White NJ
    Br J Clin Pharmacol; 1993 Dec; 36(6):585-91. PubMed ID: 12959277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Halofantrine: a new substance for treatment of multidrug-resistant malaria.
    Nothdurft HD; Clemens R; Bock HL; Löscher T
    Clin Investig; 1993 Jan; 71(1):69-73. PubMed ID: 8453264
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of the safety and efficacy of micronized halofantrine in the treatment of semi-immune patients with acute, Plasmodium falciparum malaria.
    Ramsay AR; Msaki EP; Kennedy N; Ngowi FI; Gillespie SH
    Ann Trop Med Parasitol; 1996 Oct; 90(5):461-6. PubMed ID: 8915121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and pharmacokinetics of intravenous nanocapsule formulations of halofantrine in Plasmodium berghei-infected mice.
    Mosqueira VC; Loiseau PM; Bories C; Legrand P; Devissaguet JP; Barratt G
    Antimicrob Agents Chemother; 2004 Apr; 48(4):1222-8. PubMed ID: 15047523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Halofantrine-induced pruritus amongst subjects who itch to chloroquine.
    Ezeamuzie IC; Igbigbi PS; Ambakederemo AW; Abila B; Nwaejike IN
    J Trop Med Hyg; 1991 Jun; 94(3):184-8. PubMed ID: 1828840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Halofantrine in the treatment of falciparum malaria.
    Yousaf M; Bilal M
    J Pak Med Assoc; 1998 May; 48(5):155. PubMed ID: 9813982
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacokinetics of halofantrine in the rat: stereoselectivity and interspecies comparisons.
    Brocks DR; Toni JW
    Biopharm Drug Dispos; 1999 Apr; 20(3):165-9. PubMed ID: 10211870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 566C80: a potent broad spectrum anti-infective agent with activity against malaria and opportunistic infections in AIDS patients.
    Hudson AT; Dickins M; Ginger CD; Gutteridge WE; Holdich T; Hutchinson DB; Pudney M; Randall AW; Latter VS
    Drugs Exp Clin Res; 1991; 17(9):427-35. PubMed ID: 1822435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of prior administration of amodiaquine on the disposition of halofantrine in healthy volunteers.
    Omoruyi SI; Onyeji CO; Daniyan MO
    Ther Drug Monit; 2007 Apr; 29(2):203-6. PubMed ID: 17417075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.